CATHRYN DE GUZMAN: Open Payments
NPI 1033778576 · MECCA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$415 in 11 payments from 6 companies in 2025. Trend: 2023 $746 · 2024 $264 · 2025 $415
Food & beverage: $415
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 3 | $145 |
| Novo Nordisk Inc | 1 | $111 |
| Lilly USA, LLC | 3 | $76 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $51 |
| Hologic Sales and Service, LLC | 1 | $16 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
Products named: REPATHA, Ozempic, Kerendia, TRULICITY, ZEPBOUND, OTEZLA, MOUNJARO, APTIMA.
Industry payments across CA — which companies pay providers there.
